XM does not provide services to residents of the United States of America.
J
J

JacobsEngineering

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. Microstrategy, Snowflake, Target

U.S. RESEARCH ROUNDUP-Microstrategy, Snowflake, Target Nov 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Microstrategy, Snowflake and Target, on Thursday. HIGHLIGHTS * Dycom Industries Inc DY.N : D.A. Davidson raises target price to $220 from $210 * Microstrategy Inc MSTR.O : BTIG raises target price to $570 from $290 * Snowflake Inc SNOW.N : Piper Sandler raises target price to $185 from $165 * Target Corp TGT.
B
G
G
G
N
B
B
C
J
L

U.S. Microstrategy, Snowflake, Target

CORRECTED-U.S. RESEARCH ROUNDUP-Microstrategy, Snowflake, Target Corrects company name to Aclaris Therapeutics in table entry for Cantor Fitzgerald's research action Nov 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Microstrategy, Snowflake, and Target, on Thursday. HIGHLIGHTS * Dycom Industries Inc DY.N : D.A.
N
N
S
S
J
R

U.S. STOCKS Merck, Microstrategy, Illumina

U.S. STOCKS ON THE MOVE-Merck, Microstrategy, Illumina Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the tech-heavy Nasdaq edged higher on Tuesday, paring earlier losses as investors assessed Russia's warning to the United States with a new nuclear doctrine, and awaited quarterly results from AI-heavyweight Nvidia.
G
I
I
I
N
K
U
U
U
J
L

U.S. STOCKS Merck, Microstrategy Inc, Zepp Health Corp

BUZZ-U.S. STOCKS ON THE MOVE-Merck, Microstrategy Inc, Zepp Health Corp Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell on Tuesday, as escalating tensions between Russia and Ukraine dented risk appetite globally and sent investors rushing for safe-haven assets.
G
I
I
K
U
U
J
L

Jacobs Solutions Inc reports results for the quarter ended September 30 - Earnings Summary

Jacobs Solutions Inc reports results for the quarter ended September 30 - Earnings Summary Jacobs Solutions Inc J.N reported quarterly adjusted earnings of $1.37​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of $1.96. The mean expectation of fourteen analysts for the quarter was for earnings of $1.54 per share.
J

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.